PJA1 and neoplasm: Our animal experiments show that both genetic and pharmacological inhibition of the PJA1‐GLO1 pathway amplifies the efficacy of ferroptosis‐targeted therapies in xenograft, orthotopic, and patient‐derived tumor models.